Related Experiment Video
Updated: Apr 3, 2026

05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
2.1K
Structural self-organization of C60 and cisplatin in physiological solution
Yu I Prylutskyy1, V V Cherepanov, M P Evstigneev
1Taras Shevchenko National University of Kyiv, Volodymyrska Str. 64, 01601 Kyiv, Ukraine. prylut@ukr.net.
Physical Chemistry Chemical Physics : PCCP
|September 18, 2015
Summary
Structural self-organization of C60 fullerene and cisplatin (Cis) in saline solution was studied. Researchers discovered the formation of C60 + Cis complexes, explaining the synergistic effects of this drug combination.
Area of Science:
- Nanomedicine
- Materials Science
- Biochemistry
Background:
- Cisplatin (Cis) is a widely used chemotherapy drug.
- Fullerenes, like C60, are novel nanomaterials with potential therapeutic applications.
- The combination of C60 fullerene and cisplatin has shown synergistic antitumor effects, but the underlying mechanism is not fully understood.
Purpose of the Study:
- To investigate the structural self-organization of C60 fullerene and cisplatin in a physiological solution.
- To elucidate the mechanism behind the observed medico-biological synergy when C60 fullerene and cisplatin are administered together.
Main Methods:
- Small-angle neutron scattering
- Scanning electron microscopy (SEM)
- Atomic force microscopy (AFM)
- Isothermal titration calorimetry (ITC)
- Dynamic light scattering (DLS)
- UV-Vis spectroscopy
Main Results:
- The study revealed specific self-organization features of C60 fullerene and cisplatin in 0.9% NaCl solution.
- Evidence for the formation of C60 + Cis complexes was observed.
- These findings provide insights into the synergistic interaction between C60 fullerene and cisplatin.
Conclusions:
- The formation of C60 + Cis complexes is a key factor in the synergistic antitumor activity of the C60 fullerene-cisplatin combination.
- Understanding this self-organization mechanism can aid in the development of more effective nanomedicine-based cancer therapies.

